Please assess the completion status of the following clinical trial:

Trial Title: CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Signed informed consent form~* A diagnosis of pancreatic ductal adenocarcinoma~Exclusion Criteria:~* Patients unable to provide informed consent~* Women who are pregnant or intending to become pregnant during the study~* Patients with body mass index greater than 40 kg/m\^2~* History of severe allergic-like reaction to iodinated contrast media

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diagnostic (CT perfusion sequence) (Type: EXPERIMENTAL): Patients undergo CT perfusion sequence during the first 40 seconds of the baseline standard of care CT scan and during follow-up CT scans at 2 and possibly 4 months after chemotherapy, at 4-6 weeks after radiation therapy, or prior to definitive surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).